Pharmacopoeial impurityKetobemidone EP Impurity BCat. No. P-K005-002CAS 64058-44-2Family · Pharmaceutical analytical standards
Ketobemidone
A powerful synthetic opioid analgesic, comparable to morphine, first synthesised in Germany in 1942 by Eisleb and colleagues: the first study in humans was published in 1946, and it entered clinical use shortly afterwards. This family brings together pharmacopoeial impurities.
Did you know?Besides acting on opioid receptors, it partly blocks NMDA receptors, helped by its metabolite norketobemidone: this is why it can help with pain that responds poorly to other opioids.
Pharmacopoeial impurityKetobemidone EP Impurity BCat. No. P-K005-002CAS 64058-44-2
Pharmacopoeial impurityKetobemidone EP Impurity CCat. No. P-K005-003CAS 15847-72-0No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
ImpurityKetobemidone impurity B CRSEDQM code Y0000244Family KetobemidoneImpurityKetobemidone impurity C CRSEDQM code Y0000245Family KetobemidoneNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.